PEPTIDE PROTOCOLS

71 compounds. One record of the protocol, dose by dose.

Kinosis records the protocol your clinician sets — dose, unit, route, weekdays, cycles, timing — and every dose, injection site and side effect between visits.

Many peptides are not approved by the FDA for human use. Kinosis records what you and your care team set and log; it does not give medical advice or dosing recommendations. Peptide protocols should be supervised by a licensed clinician.

What Kinosis tracks

Dose and unit

mcg, mg, IU, mL or syringe units, exactly as set. A dose far outside the usual range for its unit gets one question, never a correction.

Route and injection site

Subcutaneous, intramuscular, nasal, oral or topical. The site of each injection, with the last one shown before the next.

Schedules and cycles

Set weekdays, every few days, weekly, on/off cycles and pauses. Reminders come only on due days; nothing is due or missed during an off period.

Timing and fasting

The time of day and fasting your clinician set, shown in each reminder and confirmed with one tap.

Adherence on expected doses

A weekly injection taken once is one of one, not one of seven. A dose never confirmed counts as missed.

Side effects per item

When you tie a symptom to a compound (“the site is red after the BPC”), it is recorded against that item.

For prescribers

Design your protocols: every compound with its dose, unit, route, weekdays, cycle, timing and fasting.
Share them with the practitioners you train: they import their own copy, credited to you.
Follow each patient between visits: adherence per compound, injection sites, side effects, and alerts when a cycle is ending or a side effect repeats.

Kinosis for providers →

Compounds

Routes and the default unit Kinosis checks against. Regulatory status is shown where a primary source confirms it.

GLP-1 AND METABOLIC

Semaglutide SC · oral mg FDA-approved drug · source

Tirzepatide (compounded) SC mg FDA-approved drug · source

Liraglutide SC mg FDA-approved drug · source

Dulaglutide SC mg FDA-approved drug · source

Exenatide SC mcg FDA-approved drug · source

Retatrutide SC mg Investigational · source

Cagrilintide SC mg Investigational · source

Survodutide SC mg Investigational · source

Mazdutide SC mg Approved outside the US · source

Pramlintide SC mcg FDA-approved drug · source

AOD-9604 SC mcg Research compound, not approved · source

MOTS-c SC mg Investigational · source

Tesamorelin SC mg FDA-approved drug · source

Setmelanotide SC mg FDA-approved drug · source

GROWTH HORMONE AXIS

Sermorelin SC mcg FDA-approved drug · source

CJC-1295 (no DAC) SC mcg Research compound, not approved · source

CJC-1295 with DAC SC mcg Investigational · source

Ipamorelin SC mcg Investigational · source

CJC-1295 / Ipamorelin SC mcg

GHRP-2 SC mcg Approved outside the US · source

GHRP-6 SC mcg Research compound, not approved · source

Hexarelin SC mcg

Tesamorelin / Ipamorelin SC mg

IGF-1 LR3 SC mcg

Mecasermin SC mg FDA-approved drug · source

MGF / PEG-MGF SC · IM mcg Research compound, not approved · source

Follistatin-344 SC mcg Research compound, not approved · source

REPAIR AND RECOVERY

BPC-157 SC · IM · oral · nasal mcg Investigational · source

TB-500 SC · IM mg Research compound, not approved · source

BPC-157 / TB-500 SC mcg

BPC-157 / TB-500 / GHK-Cu / KPV SC mg

GHK-Cu (injectable) SC mg Research compound, not approved · source

GHK-Cu (topical) topical application Investigational · source

KPV SC · oral · topical mcg Research compound, not approved · source

LL-37 SC · topical mcg Investigational · source

ARA-290 SC mg Investigational · source

Larazotide oral mg Investigational · source

VIP nasal · SC mcg Approved outside the US · source

PE-22-28 SC · nasal mcg

IMMUNE

Thymosin alpha-1 SC mg Approved outside the US · source

Thymalin SC · IM mg Approved outside the US · source

Thymulin SC mcg

COGNITIVE, SLEEP AND MOOD

Semax nasal · SC mcg Approved outside the US · source

Selank nasal · SC mcg Approved outside the US · source

Cerebrolysin IM · IV mL Approved outside the US · source

Dihexa oral · topical mg Research compound, not approved · source

P21 nasal · SC mg

Pinealon SC · oral mg

DSIP SC mcg Approved outside the US · source

Oxytocin nasal · SC · IM IU FDA-approved drug · source

LONGEVITY AND MITOCHONDRIAL

Epithalon SC mg Research compound, not approved · source

SS-31 SC mg FDA-approved drug · source

Humanin SC · nasal mcg

FOXO4-DRI SC mg

Vilon SC mg

SEXUAL HEALTH, SKIN AND HORMONES

Bremelanotide (PT-141) SC · nasal mg FDA-approved drug · source

Melanotan II SC · nasal mcg Investigational · source

Afamelanotide implant mg FDA-approved drug · source

Kisspeptin-10 SC mcg Investigational · source

Gonadorelin SC mcg FDA-approved drug · source

hCG SC · IM IU FDA-approved drug · source

BONE AND OTHER APPROVED PEPTIDES

Teriparatide SC mcg FDA-approved drug · source

Abaloparatide SC mcg FDA-approved drug · source

Octreotide SC mcg FDA-approved drug · source

OFTEN PRESCRIBED ALONGSIDE

NAD+ (injectable) SC · IM · IV mg

Glutathione (injectable) IM · IV mg Approved outside the US · source

5-Amino-1MQ oral mg

Methylene blue oral mg FDA-approved drug · source

Vitamin B12 injection IM · SC mcg

Lipotropic injection IM mL

Tesofensine oral mg Investigational · source

Download the App Try on WhatsApp